title: Para-Tyrosine Supplementation Improves Insulin- and Liraglutide- Induced Vasorelaxation in Cholesterol-Fed Rats.
abstract: Former data of our workgroup indicated that the accumulation of oxidized amino acids (meta- and ortho-tyrosine) due to oxidative stress may play an important role in the impaired insulininduced vasoactive properties of different arterial segments. There are evidences, that incorporation of these amino acids into cellular proteins leads to certain hormonal resistances, which might be restored by supplementation with the physiologic isoform, para-tyrosine. Rats in the control group were kept on a regular diet, rats in the cholesterol-fed group received high-fat diet, while the third group of rats received high-fat diet with para-tyrosine supplementation for 16 weeks. Plasma cholesterol level was significantly higher in the cholesterol-fed group, while the level of cholesterol in the cholesterol+para-tyrosine group did not differ significantly from that of the controls. Plasma level of insulin after glucose stimulation was decreased in the cholesterol-fed group, while that in the para-tyrosine supplemented group did not differ significantly from the controls. Vascular para-, meta- and ortho-tyrosine content was measured with HPLC. Elevated vascular meta-tyrosine/para-tyrosine ratio of cholesterol fed rats could be avoided by para-tyrosine supplementation. Vascular response of the thoracic aorta to insulin and liraglutide was assessed by a DMT multi-myograph. Cholesterol feeding resulted in vascular insulin-and liraglutide resistance, which was restored by para-tyrosine supplementation. Incorporation of the oxidative stress induced pathological tyrosine isoforms leads to vascular-hormone-resistances. We show that the physiological amino acid para-tyrosine is capable of restoring hypercholesterolemia-induced increased meta-tyrosine content of the vascular wall, thus attenuating functional vascular damage.
authors.forename: Eszter
authors.initials: E
authors.lastname: Sélley
authors.forename: Szilárd
authors.initials: S
authors.lastname: Kun
authors.forename: Mária
authors.initials: M
authors.lastname: Kürthy
authors.forename: Tibor
authors.initials: T
authors.lastname: Kovács
authors.affiliation: University of Pécs, Faculty of Medicine, 2nd Department of Medicine and Nephrological Centre, 1st Pacsirta St., H-7624 Pécs, Hungary. istvan.wittmann@aok.pte.hu.
authors.forename: István
authors.initials: I
authors.lastname: Wittmann
authors.forename: Gergo A
authors.initials: GA
authors.lastname: Molnár
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000187:drug effects; D002784:Cholesterol / Q000378:metabolism*; D059305:Diet, High-Fat; D007328:Insulin / Q000097:blood / Q000494:pharmacology*; D000069450:Liraglutide / Q000494:pharmacology*; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D014443:Tyrosine / Q000008:administration & dosage / Q000494:pharmacology*; D014664:Vasodilation / Q000187:drug effects*
chemical_list: D001786:Blood Glucose; D007328:Insulin; D014443:Tyrosine; D000069450:Liraglutide; D002784:Cholesterol